The growth of the serum-free media market is attributed to the growing demand for biopharmaceuticals coupled with technological advancements in cell culture and regulatory requirements. Such market growth has been bolstered by initiatives and funding provided by governments. The National Institutes of Health (NIH) budgeted 41.7 billion dollars for fiscal year 2020, much of which was in cell culture, or other related technologies.